- Page 1 and 2:
CURRENT INTELLIGENCE BULLETIN 65Occ
- Page 3 and 4:
Current Intelligence Bulletin 65Occ
- Page 5 and 6:
ForewordThe Occupational Safety and
- Page 7 and 8:
Executive SummaryOverviewCarbon nan
- Page 9 and 10:
2009; Pauluhn 2010a; Porter et al.
- Page 11 and 12:
neurogenic sig nals from sensory ir
- Page 13 and 14:
possible. Until the results from an
- Page 15 and 16:
••Follow exposure and hazard as
- Page 17 and 18:
Periodic Evaluations••Evaluatio
- Page 19 and 20:
ContentsForeword ..................
- Page 21 and 22:
A.3.2 Comparison of Short-term and
- Page 23 and 24:
ESPFeFMPSFPSSgGMGSDHCLHECHEPAhrISOI
- Page 25 and 26:
AcknowledgementsThis Current Intell
- Page 27 and 28:
1 IntroductionMany nanomaterial-bas
- Page 29:
2 Potential for ExposureThe novel a
- Page 32 and 33:
CNMs, with MWCNT agglomerates obser
- Page 34 and 35:
composite materials with local exha
- Page 36 and 37:
information on air contaminants. Sa
- Page 39 and 40:
3 Evidence for Potential Adverse He
- Page 41 and 42:
decreasing agglomerate size increas
- Page 43 and 44:
examined up to 60 days post-exposur
- Page 45 and 46:
3.3 SWCNT and MWCNTIntraperitoneal
- Page 47 and 48:
The same potency sequence was obser
- Page 49 and 50:
Table 3-3. Findings from published
- Page 51 and 52:
Table 3-5. Findings from published
- Page 53 and 54:
Table 3-6. Findings from published
- Page 55 and 56:
Table 3-7 (Continued). Findings fro
- Page 57:
Table 3-8. Findings from published
- Page 60 and 61:
length, respectively) [Muller et al
- Page 63 and 64:
5 CNT Risk Assessment and Recommend
- Page 65 and 66: A-6). Risk estimates derived from o
- Page 67 and 68: Table 5-4. Factors, assumptions, an
- Page 69 and 70: and analytical methods. NIOSH is re
- Page 71 and 72: Table 5-5. Recommended occupational
- Page 73 and 74: deficits in animals or clinically s
- Page 75: (3) Rat lung dose estimationIn the
- Page 78 and 79: tasks where worker exposures exceed
- Page 80 and 81: As part of the evaluation of worker
- Page 82 and 83: Table 6-1. EC LODs and LOQs for 25-
- Page 84 and 85: 6.2 Engineering ControlsOne of the
- Page 86 and 87: Table 6-6 (Continued). Examples of
- Page 88 and 89: Table 6-7 (Continued). Engineering
- Page 90 and 91: exposure estimates for SWCNT on ind
- Page 92 and 93: Table 6-8. Respiratory protection f
- Page 94 and 95: ••Workers in areas or in jobs w
- Page 97 and 98: 7 Research NeedsAdditional data and
- Page 99 and 100: ReferencesACGIH [1984]. Particle si
- Page 101 and 102: Bolton RE, Vincent HJ, Jones AD, Ad
- Page 103 and 104: eport issued on July 22, 2011. NEDO
- Page 105 and 106: Kobayashi N, Naya M, Mizuno K, Yama
- Page 107 and 108: Methner M, Hodson L, Geraci C [2010
- Page 109 and 110: Human Services, Centers for Disease
- Page 111 and 112: Piegorsch WW, Bailer AF [2005]. Qua
- Page 113 and 114: AD, Baron PA [2003]. Exposure to ca
- Page 115: Varga C, Szendi K [2010]. Carbon na
- Page 120 and 121: A.7 Evaluation of Carbon Nanofiber
- Page 122 and 123: found that the effective surface ar
- Page 124 and 125: of these studies also provide dose-
- Page 126 and 127: and three routes of exposure to sev
- Page 128 and 129: Table A-2. CNT particle size and al
- Page 130 and 131: to a toxicant, and at some point, t
- Page 132 and 133: Figure A-1. Benchmark dose model (m
- Page 134 and 135: Figure A-3. Benchmark dose model fi
- Page 136 and 137: and reference worker conditions, in
- Page 138 and 139: Table A-4. Benchmark dose estimates
- Page 140 and 141: Table A-6. Benchmark dose estimates
- Page 142 and 143: Table A-7. Working lifetime percent
- Page 144 and 145: Tables A-7 and A-8 provide working
- Page 146 and 147: (see Section A.6.1 for sensitivity
- Page 148 and 149: SWCNT on a mass basis is likely due
- Page 150 and 151: NOAEL based on subchronic inhalatio
- Page 152 and 153: particle in question. Conventionall
- Page 154 and 155: Table A-11. Comparison of MPPD mode
- Page 156 and 157: Table A-12. Effect level estimates
- Page 158 and 159: humans (H) or animals (A); DF is th
- Page 160 and 161: species based on the total alveolar
- Page 162 and 163: particle retention predicted by the
- Page 164 and 165: Table A-14. Example of uncertainty
- Page 166 and 167:
nificant only in the rats exposed t
- Page 168 and 169:
etween the estimated deposited and
- Page 171 and 172:
APPENDIX BOccupational Health Surve
- Page 173:
3. Presentation of the findings to
- Page 176 and 177:
C.1 BackgroundNIOSH Method 5040 is
- Page 178 and 179:
the thermal-optical instrument was
- Page 180 and 181:
sampler type, and as expected, diff
- Page 182:
Table 1. NIOSH 5040 precision for a